U.S. Home Healthcare Market is estimated to be valued at USD 26.59 Bn in 2025 and is expected to reach USD 40.78 Bn in 2032, ...

In a study published in eClinicalMedicine, researchers at the German Diabetes Center (DDZ) show that automated insulin ...

An AI tool showed noninferiority to senior endocrinology physicians in insulin titration for hospitalized patients with type ...

Adult inpatients with T2D and recent antidiabetic treatment were randomly assigned to receive insulin dose adjustments over ...

Purpose: The pharmacology, pharmacokinetics, efficacy and tolerability, safety, drug interactions, dosage and administration, cost, and place in therapy of insulin detemir are reviewed.

Amphastar Pharmaceuticals posted Q1 results last week that beat the bottom-line consensus. The stock appears cheap at under ...

TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

granted Breakthrough Therapy Designation to veligrotug ("veli"), the company’s lead anti-insulin-like growth factor-1 receptor (IGF-1R) drug candidate for the treatment of TED. Breakthrough ...

AUSTIN, Texas, May 7, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...

More than 38 million people in the US have been diagnosed with diabetes, and about 8.4 million Americans rely on insulin therapy. "For the millions of people who rely on daily injections of ...